Healthcare
 and Life Sciences

Biozeus is the leading company in the development of new drugs for human health from Brazil to the world. Biozeus has an international presence and a robust set of scientific, business, and project management skills necessary to identify, license and develop new drugs that contribute to a longer and better life.

Placi is the first Brazilian network of transitional care hospitals. Leader in its segment, Placi offers services for patients who need complex care and/or rehabilitation, with high quality and excellent cost-effectiveness.

Lifemed is the main Brazilian company in the development, production, and sale of medical equipment and its inputs. The company adopts a leading position by consistently investing in the development of new products, services, and technologies, with a portfolio of integrated solutions for the hospital environment.

Timpel is a medical equipment company that has developed an innovative cardiopulmonary monitoring platform based on Electrical Impedance Technology (EIT), which mitigates the risks of the mechanical ventilation procedure and contributes to increasing the survival rate in ICUs. Currently, the equipment produced by Timpel is the world leader in its segment and has regulatory approval in Brazil, Europe, Japan, and the USA.

Mendelics is the first and leading diagnostic laboratory in Latin America dedicated to genomic analysis. It has a team with high scientific and operational capacity, as well as a robust portfolio of testing and interpretation protocols for genomic variants, which is in constant development and guarantees its differentiated performance in Brazil, in addition to a relevant international presence.

Vitta Tecnologia em Saúde SA is a digital health care company, created in 2014, which offers its own network of health professionals and clinics, complementary to health plans and drugstore chains that offer drugs with discounts. In 2020 the company was sold to Stone.

Mevo is a healthcare platform, founded in 2017 as Nexodata, which offers solutions ranging from digital prescriptions to the delivery of medicines to patients' homes. In 2021, the founders repurchased FINVEST's stake.

Securitas BioSciences is a venture builder of biotechnology companies, with a strong presence in Boston and preferably focused on Latin America, in special Brazil and Argentina. Its purpose is to make resources available so that scientists in the region can convert their scientific research into businesses that improve the population’s well-being.